Literature DB >> 14630987

A swine model of horse serum-induced coronary vasculitis: an implication for Kawasaki disease.

Saji Philip1, Wen-Chuan Lee, Si-Kwang Liu, Mei-Hwan Wu, Hung-Chi Lue.   

Abstract

An attempt was made to induce immune complex vasculitis by horse serum (HS) infusions in piglets, hoping to produce experimental coronary artery lesions that mimic Kawasaki disease. A total of 21 purebred male piglets of 1.5, 2.5, and 3 mo were divided into HS (n = 14) and control, normal saline (NS; n = 7) groups. In seven piglets, 5 mL/kg of HS was infused, then repeated with 10 mL/kg 10 d later. In another seven piglets, 10 mL/kg of HS was infused three times at 5-d intervals. In three piglets in the control group, 5 and 10 mL/kg of NS was infused at 10-d intervals. In another four piglets of the control group, 10 mL/kg of NS was infused three times at 5-d intervals. Two-dimensional echocardiographic examinations for visualization and measurement of the coronary arteries were done before and after infusions at 4- to 5-d interval. Hematology examination showed that white blood cells and platelets decreased, then increased. The animals were killed at 14-60 d after the first infusion of HS or NS, for histopathologic and immunohistochemical studies. All HS groups developed skin rashes and echocardiographic evidence of coronary artery dilation and histopathologic changes of vasculitis. None in the NS group developed vasculitis. The main changes of the coronary vasculitis were intimal proliferation, smooth muscle cell necrosis, and vacuolization changes. Those that received three HS infusions developed more skin rashes than those that received two infusions. It is concluded that piglets may serve as an experimental model for immune complex vasculitis involving the coronary arteries with skin rashes mimicking Kawasaki disease.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14630987     DOI: 10.1203/01.PDR.0000104151.26375.E5

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  5 in total

Review 1.  Recent Advances in Kawasaki Disease - Proceedings of the 3rd Kawasaki Disease Summit, Chandigarh, 2014.

Authors:  Surjit Singh; Dhrubajyoti Sharma; Sagar Bhattad; Saji Phillip
Journal:  Indian J Pediatr       Date:  2015-08-30       Impact factor: 1.967

2.  Polymorphism of Fc gamma RIIa may affect the efficacy of gamma-globulin therapy in Kawasaki disease.

Authors:  Shoichiro Taniuchi; Midori Masuda; Masayuki Teraguchi; Yumiko Ikemoto; Yutaka Komiyama; Hakuo Takahashi; Minoru Kino; Yohnosuke Kobayashi
Journal:  J Clin Immunol       Date:  2005-07       Impact factor: 8.317

3.  Animal models of vasculitides.

Authors:  Uriel Katz; Boris Gilburd; Yehuda Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  2008-10       Impact factor: 8.667

4.  Augmented TLR2 expression on monocytes in both human Kawasaki disease and a mouse model of coronary arteritis.

Authors:  I-Chun Lin; Ho-Chang Kuo; Ying-Jui Lin; Feng-Shen Wang; Lin Wang; Shun-Chen Huang; Shao-Ju Chien; Chien-Fu Huang; Chih-Lu Wang; Hong-Ren Yu; Rong-Fu Chen; Kuender D Yang
Journal:  PLoS One       Date:  2012-06-21       Impact factor: 3.240

5.  Vasculitis induced by immunization with Bacillus Calmette-Guérin followed by atypical mycobacterium antigen: a new mouse model for Kawasaki disease.

Authors:  Tsuneyuki Nakamura; Jun-Ichi Yamamura; Hitoshi Sato; Hiroaki Kakinuma; Hiroaki Takahashi
Journal:  FEMS Immunol Med Microbiol       Date:  2007-02-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.